← Insider buys

SYNH

Syneos Health, Inc.

No insider bought or sold Syneos Health, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

SYNH over the last year

Prices for SYNH aren't in yet.

SYNH after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

71 insider filings since 2018, newest first

SYNHSell

Michael Lee Brooks · COO

$117K−3.0%Jul 29
SYNHSell

Michael Lee Brooks · COO

$114K−3.0%Jul 22
SYNHSell

Jonathan Olefson · GC, Corp Secty

$166K−8.0%Jul 21
SYNHSell

Michael Lee Brooks · COO

$111K−2.0%Jul 20
SYNHSell

Michelle Keefe · CEO

$607K−10.0%Jul 20
SYNHSell

Jason M. Meggs · CFO

$546K−12.0%Jul 20
SYNHSell

Donna Hildebrand Kralowetz · EVP and Chief Accounting Officer

$84K−14.0%Jul 11
SYNHSell

Donna Hildebrand Kralowetz · SVP and Chief Accounting Officer

$95K−14.0%Feb 2
SYNHSell

Jonathan Olefson · GC, Corp Secty

$191K−8.0%Dec 27
SYNHSell

Linda S Harty · Director

$400K−44.0%Dec 21
SYNHSell

Jason M. Meggs · CFO

$876K−15.0%Sep 3
SYNHSell

Alistair Macdonald · CEO

$3.6M−17.0%Aug 4
SYNHSell

Jason M. Meggs · CFO

$59K−1.0%Jul 7
SYNHSell

Jason M. Meggs · CFO

$420K−7.0%Jul 2
SYNHSell

Donna Hildebrand Kralowetz · SVP and Chief Accounting Officer

$50K−8.0%Jun 21
SYNHSell

John L. Maldonado · Director

$512.2M−100.0%Jun 9
SYNHSell

Tom Allen · Director

$512.2M−100.0%Jun 9
SYNHSell

Thomas H. Lee Advisors, LLC · Director

$409.6M−100.0%Jun 9
SYNHSell

Advent International Corp/ma · 10% owner

$512.2M−100.0%Jun 9
SYNHSell

Alistair Macdonald · CEO

$431K−2.0%Jun 3
SYNHSell

Thomas H. Lee Advisors, LLC · Director

$30.8M−7.0%May 20
SYNHSell

John L. Maldonado · Director

$36.4M−7.0%May 18
SYNHSell

Tom Allen · Director

$36.4M−7.0%May 18
SYNHSell

Advent International Corp/ma · 10% owner

$36.4M−7.0%May 18
SYNHSell

Tom Allen · Director

$324.8M−37.0%May 10
SYNHSell

John L. Maldonado · Director

$324.8M−37.0%May 10
SYNHSell

Thomas H. Lee Advisors, LLC · Director

$274.9M−38.0%May 10
SYNHSell

Advent International Corp/ma · 10% owner

$324.8M−37.0%May 10
SYNHSell

Jason M. Meggs · CFO

$504K−9.0%Apr 16
SYNHSell

Michelle Keefe · Pres, Commercial Solutions

$224K−6.0%Apr 16
SYNHSell

Alistair Macdonald · CEO

$1.1M−7.0%Apr 12
SYNHSell

Alistair Macdonald · CEO

$1.4M−8.0%Apr 5
SYNHSell

Michelle Keefe · Pres, Commercial Solutions

$156K−4.0%Apr 1
SYNHSell

Linda S Harty · Director

$559K−51.0%Mar 31
SYNHSell

Jonathan Olefson · GC, Corp Secty

$308K−14.0%Mar 31
SYNHSell

John L. Maldonado · Director

$345.2M−30.0%Mar 5
SYNHSell

Tom Allen · Director

$345.2M−30.0%Mar 5
SYNHSell

Thomas H. Lee Advisors, LLC · Director and 10% owner

$296.4M−30.0%Mar 5
SYNHSell

Advent International Corp/ma · 10% owner

$345.2M−30.0%Mar 5
SYNHSell

Donna Hildebrand Kralowetz · SVP and Chief Accounting Officer

$29K−6.0%Feb 18
SYNHSell

Alistair Macdonald · CEO

$4.9M−23.0%Feb 3
SYNHSell

Paul Colvin · Pres, Clinical Solutions

$635K−23.0%Feb 3
SYNHSell

Jonathan Olefson · GC, Corp Secty

$404K−16.0%Jan 27
SYNHSell

Michelle Keefe · Pres, Commercial Solutions

$303K−7.0%Jan 27
SYNHSell

Jason M. Meggs · CFO

$400K−9.0%Jan 7
SYNHSell

Alistair Macdonald · CEO

$105K−1.0%Dec 28
SYNHSell

Tom Allen · Director

$197.8M−17.0%Dec 7
SYNHSell

John L. Maldonado · Director

$197.8M−17.0%Dec 7
SYNHSell

Thomas H. Lee Advisors, LLC · Director and 10% owner

$169.9M−17.0%Dec 7
SYNHSell

Advent International Corp/ma · 10% owner

$197.8M−17.0%Dec 7

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.